SCHEMBL1607606

SCHEMBL1607606

CCc1c(O)cccc1CCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 4/20 0.50
AKR1B1 P15121 1/20 0.44
POLB P06746 1/20 0.44
PTGER1 P34995 1/20 0.44
PTGER4 P35408 1/20 0.44
PTGER3 P43115 1/20 0.44
PTGER2 P43116 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB2 P47870 1/20 0.44
BID P55957 3/20 0.43
MCL1 Q07820 3/20 0.43
BCL2L1 Q07817 2/20 0.43
BAK1 Q16611 2/20 0.43
KAT8 Q9H7Z6 2/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
EP300 Q09472 1/20 0.43
KAT2A Q92830 1/20 0.43
KAT2B Q92831 1/20 0.43
KAT5 Q92993 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31086284 0.87 IAPP (0.49) IAPPAKR1B1POLBPTGER1PTGER4
SCHEMBL26046345 0.84 IAPP (0.46) IAPPAKR1B1POLBPTGER1PTGER4
Benzene SCHEMBL10833201 0.83 GABRA1 (0.56) IAPPAKR1B1GABRA1GABRB2BID
Malonic Acid SCHEMBL6129177 0.82 AKR1B1 (0.47) IAPPAKR1B1GABRA1GABRB2BID
SCHEMBL559437 0.82 AKR1B1 (0.62) IAPPAKR1B1POLBGABRA1GABRB2
SCHEMBL24693642 0.82 POLB (0.51) IAPPAKR1B1POLBPTGER1PTGER4
SCHEMBL1262379 0.81 MEN1 (0.46) PTGER1PTGER4PTGER3PTGER2NPSR1
SCHEMBL7611074 0.81 NPSR1 (0.52) POLBPTGER1PTGER4PTGER3PTGER2
SCHEMBL30116230 0.81 GABRA1 (0.58) IAPPAKR1B1GABRA1GABRB2BID
SCHEMBL707284 0.81 GABRA1 (0.58) IAPPAKR1B1GABRA1GABRB2BID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
US-6844302-B1 Encapsulated flavor and fragrance INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2005-01-18 US claimed
EP-1056739-B1 NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE PROCTER & GAMBLE (US) 2003-05-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed
US-12624216-B2 Method for the production of free-flowing granules OMYA INTERNATIONAL AG (CH) 2026-05-12 US disclosed
EP-4142675-B1 GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS EXCIPIENT OMYA INT AG (CH) 2026-03-25 EP disclosed
EP-4143136-B1 METHOD FOR THE PRODUCTION OF FREE-FLOWING GRANULES OMYA INT AG (CH) 2025-09-10 EP disclosed
US-20240327232-A1 METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL OMYA INTERNATIONAL AG (CH) 2024-10-03 US disclosed
EP-4396133-A1 METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL Omya International AG (CH) 2024-07-10 EP disclosed
EP-4146743-B1 COATINGS COMPRISING ANTIMICROBIAL ACTIVE INGREDIENTS FOR FOOD PACKAGING OMYA INT AG (CH) 2024-07-03 EP disclosed
US-20230201126-A1 SURFACE-REACTED CALCIUM CARBONATE IN A PROCESS FOR THE PRODUCTION OF A LOADED MICROCAPSULE OMYA INTERNATIONAL AG (CH) 2023-06-29 US disclosed
US-20230183499-A1 COATINGS COMPRISING ANTIMICROBIAL ACTIVE INGREDIENTS FOR FOOD PACKAGING OMYA INTERNATIONAL AG (CH) 2023-06-15 US disclosed
WO-1998007455-A1 ODOR CONTROL COMPOSITIONS COMPRISING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007683-A1 PROCESS FOR PREPARING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007809-A2 HARD SURFACE CLEANERS COMPRISING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007811-A2 RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE DERIVATIVES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007405-A1 FRAGRANCE DELIVERY SYSTEMS THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007814-A2 FRAGRANCE DELIVERY SYSTEM FOR LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007810-A2 HAND-WASH LAUNDRY DETERGENT COMPOSITIONS COMPRISING BETA-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998006803-A1 RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS THE PROCTER & GAMBLE COMPANY (US) 1998-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624216-B2 Method for the production of free-flowing granules TMCO1, ORAI1, CACNA1G IAPP 1273/4885AKR1B1 4877/4885POLB 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.